Unique ID issued by UMIN | UMIN000058934 |
---|---|
Receipt number | R000067400 |
Scientific Title | Prognostic impact of MES 1 inflammatory extent on remission maintenance in ulcerative colitis |
Date of disclosure of the study information | 2025/08/29 |
Last modified on | 2025/08/29 20:44:24 |
Prognostic impact of MES 1 inflammatory extent on remission maintenance in ulcerative colitis
Prognostic impact of MES 1 inflammatory extent on remission maintenance in ulcerative colitis
Prognostic impact of MES 1 inflammatory extent on remission maintenance in ulcerative colitis
Prognostic impact of MES 1 inflammatory extent on remission maintenance in ulcerative colitis
Japan |
Ulcerative colitis
Gastroenterology |
Others
NO
The aim of this study was to retrospectively analyze the impact of the extent of inflammation distribution on the remission maintenance rate in patients with UC evaluated as MES 1 and to reevaluate whether all MES 1 inflammation should be treated equally or not.
Others
The aim of this study was to retrospectively analyze the impact of the extent of inflammation distribution on the remission maintenance rate in patients with UC evaluated as MES 1 and to reevaluate whether all MES 1 inflammation should be treated equally or not.
The primary endpoint of this study is to evaluate the two-year clinical remission maintenance rate based on the extent of inflammation classified as MES 1.
Observational
15 | years-old | <= |
85 | years-old | >= |
Male and Female
Patients with UC who were treated at the Department of Gastroenterology, Dokkyo Medical University Hospital between January 1, 2008, and December 31, 2023, had an MES of 0 or 1 at the initial endoscopic assessment after remission induction therapy without any change in remission maintenance therapy, and had available follow-up data for two years after the endoscopy were enrolled.
The following cases were excluded from the study: cases with left-sided colitis or proctitis; cases in which no endoscopic examination was performed after remission induction; cases in which total colonoscopy was not performed; cases that had an MES of 2 or 3 at the initial endoscopic assessment after remission induction therapy; cases in which the clinical course could not be followed for two years after endoscopy; cases with a history of colonic surgery; cases receiving immunosuppressive therapy for other diseases; cases in which the patient refused to participate in the study; and cases deemed inappropriate for inclusion in this study by the investigators.
300
1st name | Mimari |
Middle name | |
Last name | Kanazawa |
Dokkyo Medical University School of Medicine
Department of Gastroenterology
3210293
880, Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan
+81-282-87-2147
mimari77@dokkyomed.ac.jp
1st name | Mimari |
Middle name | |
Last name | Kanazawa |
Dokkyo Medical University School of Medicine
Department of Gastroenterology
3210293
880, Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan
+81-282-87-2147
mimari77@dokkyomed.ac.jp
Dokkyo Medical University School of Medicine
None.
Other
The ethics committee of Dokkyo Medical University Hospital
880, Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan
+81-282-87-2147
r-kenkyu@dokkyomed.ac.jp
NO
2025 | Year | 08 | Month | 29 | Day |
Unpublished
301
No longer recruiting
2025 | Year | 08 | Month | 29 | Day |
2024 | Year | 12 | Month | 04 | Day |
2025 | Year | 08 | Month | 29 | Day |
2025 | Year | 12 | Month | 31 | Day |
None.
2025 | Year | 08 | Month | 29 | Day |
2025 | Year | 08 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067400